These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 34357802)

  • 21. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pseudomonas aeruginosa Effector ExoS Inhibits ROS Production in Human Neutrophils.
    Vareechon C; Zmina SE; Karmakar M; Pearlman E; Rietsch A
    Cell Host Microbe; 2017 May; 21(5):611-618.e5. PubMed ID: 28494242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro.
    Antos M; Trafny EA; Grzybowski J
    Pharmacol Res; 1995; 32(1-2):85-7. PubMed ID: 8668652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin.
    Sun Z; Shi J; Liu C; Jin Y; Li K; Chen R; Jin S; Wu W
    Infect Immun; 2014 Apr; 82(4):1638-47. PubMed ID: 24491574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of experimental pneumonia in rats caused by a PER-1 extended-spectrum beta-lactamase-producing strain of Pseudomonas aeruginosa.
    Mimoz O; Elhelali N; Léotard S; Jacolot A; Laurent F; Samii K; Petitjean O; Nordmann P
    J Antimicrob Chemother; 1999 Jul; 44(1):91-7. PubMed ID: 10459815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug resistant-Pseudomonas aeruginosa.
    Yasmin F; Akhtar N; Hameed A
    Pak J Pharm Sci; 2013 Sep; 26(5):1041-4. PubMed ID: 24035966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro bactericidal activities of beta-lactamases, amikacin, and fluoroquinolones against Pseudomonas aeruginosa biofilm in artificial urine.
    Goto T; Nakame Y; Nishida M; Ohi Y
    Urology; 1999 May; 53(5):1058-62. PubMed ID: 10223506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitrate Respiration Promotes Polymyxin B Resistance in
    Kim BO; Jang HJ; Chung IY; Bae HW; Kim ES; Cho YH
    Antioxid Redox Signal; 2021 Feb; 34(6):442-451. PubMed ID: 32370551
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae.
    Van Laethem Y; Lagast H; Klastersky J
    Antimicrob Agents Chemother; 1983 Mar; 23(3):435-9. PubMed ID: 6221694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of pH on adaptive resistance of Pseudomonas aeruginosa to aminoglycosides and their postantibiotic effects.
    Xiong YQ; Caillon J; Drugeon H; Potel G; Baron D
    Antimicrob Agents Chemother; 1996 Jan; 40(1):35-9. PubMed ID: 8787875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection.
    Cirioni O; Ghiselli R; Silvestri C; Minardi D; Gabrielli E; Orlando F; Rimini M; Brescini L; Muzzonigro G; Guerrieri M; Giacometti A
    J Antimicrob Chemother; 2011 Jun; 66(6):1318-23. PubMed ID: 21406436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro antimicrobial effects of aztreonam, colistin, and the 3-drug combination of aztreonam, ceftazidime and amikacin on metallo-beta-lactamase-producing Pseudomonas aeruginosa.
    Oie S; Fukui Y; Yamamoto M; Masuda Y; Kamiya A
    BMC Infect Dis; 2009 Aug; 9():123. PubMed ID: 19664245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of homocysteine and memantine on oxidative stress related TRP cation channels in
    Övey İS; Nazıroğlu M
    J Recept Signal Transduct Res; 2021 Jun; 41(3):273-283. PubMed ID: 32781866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Pahlavanzadeh F; Kalantar-Neyestanaki D; Motamedifar M; Mansouri S
    Yale J Biol Med; 2020 Mar; 93(1):29-34. PubMed ID: 32226332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pretreatment of Pseudomonas aeruginosa with a sub-MIC of imipenem enhances bactericidal activity of neutrophils.
    Sasahara T; Satoh Y; Sekiguchi T; Suzuki K; Irinoda K; Takayama Y; Sakamoto A; Kitasato H; Okamoto R; Inoue M
    J Infect Chemother; 2003 Dec; 9(4):297-303. PubMed ID: 14691649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a ciprofloxacin/amikacin combination against planktonic and biofilm cultures of susceptible and low-level resistant Pseudomonas aeruginosa.
    Soares A; Alexandre K; Lamoureux F; Lemée L; Caron F; Pestel-Caron M; Etienne M
    J Antimicrob Chemother; 2019 Nov; 74(11):3252-3259. PubMed ID: 31424553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies on the antimicrobial activities of gentamicin, amikacin, and tobramycin against Pseudomonas aeruginosa isolated at Hokkaido University Hospital].
    Sato K; Matsumiya H; Saito A
    Jpn J Antibiot; 1982 May; 35(5):1240-8. PubMed ID: 6813532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E; Zer Y; Eksi F
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
    Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
    BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.